Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
May 08, 16:00
Sinovac Biotech Revenue (TTM): 448.27M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 448.27M |
| June 30, 2023 | 420.88M |
| December 31, 2022 | 1.493B |
| June 30, 2022 | 9.606B |
| Date | Value |
|---|---|
| December 31, 2021 | 19.37B |
| June 30, 2021 | 11.09B |
| December 31, 2017 | 174.35M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
420.88M
Minimum
Jun 2023
19.37B
Maximum
Dec 2021
7.072B
Average
5.549B
Median
Revenue (TTM) Benchmarks
| CASI Pharmaceuticals Inc | 33.88M |
| Zai Lab Ltd | 266.72M |
| I-MAB | 3.914M |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | 18.11M |